NCT00541996View on ClinicalTrials.gov

Study Comparing Bioavailability of Oral Formulations of Vabicaserin

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 2007

Study Completion Date

October 31, 2007

Conditions
Schizophrenia
Interventions
DRUG

vabicaserin

Trial Locations (1)

19148

Philadelphia

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00541996 - Study Comparing Bioavailability of Oral Formulations of Vabicaserin | Biotech Hunter | Biotech Hunter